Home Transmembrane Transporters Sodium Channel inhibitor Benzocaine For research use only.

Benzocaine

Synonyms: ethyl 4-aminobenzoate

Benzocaine(ethyl 4-aminobenzoate) is the ethyl ester of p-aminobenzoic acid (PABA), it is a local anesthetic commonly used as a topical pain reliever or in cough drops.

Benzocaine Chemical Structure

Benzocaine Chemical Structure

CAS No. 94-09-7

Purity & Quality Control

Batch: S421001 DMSO]33 mg/mL]false]Ethanol]33 mg/mL]false]Water]Insoluble]false Purity: 99.93%
99.93

Benzocaine Related Products

Signaling Pathway

Sodium Channel Signaling Pathways

Sodium Channel Signaling Pathway

Biological Activity

Description Benzocaine(ethyl 4-aminobenzoate) is the ethyl ester of p-aminobenzoic acid (PABA), it is a local anesthetic commonly used as a topical pain reliever or in cough drops.
Targets
Sodium channel [1]
In vitro
In vitro

Benzocaine blocks µ1 wild-type Na+ currents in a dose-dependent manner with IC50 of 0.8 mM in HEK293T cells. Benzocaine (1 mM) blocks about 55% of wild-type Na+ current but about 95% of µ1-N1584A mutant current. Benzocaine (1 mM) blocks about 55% of wild-type µ1 currents, but about 80% of µ1-I1575A mutant current. [1] Benzocaine results in a biphasic (protective/inductive) concentration-dependent hemolytic effect upon rat erythrocytes, with an effective Benzocaine:lipid molar ratio in the membrane for protection (RePROT), onset of hemolysis (ReSAT) and 100% membrane solubilization (ReSOL) of 1.0:1, 1.1:1 and 1.3:1, respectively. [2] Benzocaine and 4-hydroxybenzoate interact with the open and inactivated channels during repetitive pulses, but during the interpulse the complex dissociates too fast to accumulate sufficient use-dependent block of Na+ currents. [3] Benzocaine (500 μM) reduces the peak and steady-state currents and increases the amplitude of the inactivating component from 21.7% to 30.2% (n=7, P<0.05), so that benzocaine-induced block at the end of pulses to +60 mV averaged 30.9% (n=7). Benzocaine (500 μM) significantly accelerates the initial phase of deactivation (τf=27.2±2.6 ms, n=7, P<0.01), but does not modify the slow phase of tail current decline. Benzocaine binds with high affinity to an intracellular binding site to produce 'agonist' effects and to a low affinity subsite, which is also located in the inner mouth, to produce the blocking effects. Benzocaine and extracellular K(+) interact to modify the voltage-dependence of channel opening. [4]
In Vivo
In vivo

Benzocaine is absorbed rapidly and similarly through both viable and nonviable skin of the hairless guinea pig, the absorption of the two acidic compounds, benzoic acid and PABA, is greater through nonviable skin. [5]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06165432 Completed
Pain
B.P. Koirala Institute of Health Sciences
 March 19 2021 Phase 4
NCT03116737 Completed
Pain|Acute Otitis Media
Lachlan Pharma Holdings
 January 3 2017 Phase 3
NCT02092454 Completed
Pain|Acute Otitis Media
Otic Therapy LLC
 September 2013 Phase 2

Chemical Information & Solubility

Molecular Weight 165.19 Formula

C9H11NO2
CAS No. 94-09-7 SDF Download Benzocaine SDF
Smiles CCOC(=O)C1=CC=C(C=C1)N
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 33 mg/mL ( (199.76 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 33 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Benzocaine | Benzocaine ic50 | Benzocaine price | Benzocaine cost | Benzocaine solubility dmso | Benzocaine purchase | Benzocaine manufacturer | Benzocaine research buy | Benzocaine order | Benzocaine mouse | Benzocaine chemical structure | Benzocaine mw | Benzocaine molecular weight | Benzocaine datasheet | Benzocaine supplier | Benzocaine in vitro | Benzocaine cell line | Benzocaine concentration | Benzocaine nmr